Kiora Pharmaceuticals to Present at The 24th Annual Needham Virtual Healthcare Conference

Core Insights - Kiora Pharmaceuticals will present at the 24th Annual Needham Virtual Healthcare Conference on April 10, 2025, at 2:15 PM EDT [1] - The presentation will include updates on the company's pipeline and planned Phase 2 clinical trials for KIO-104 and KIO-301 [2] Company Overview - Kiora Pharmaceuticals is a clinical-stage biotechnology company focused on developing therapies for retinal diseases [3] - The company targets critical pathways in retinal diseases using innovative small molecules to address vision loss [3] - KIO-301 is aimed at treating retinitis pigmentosa, choroideremia, and Stargardt disease, while KIO-104 is designed for retinal inflammation [3] Investor Engagement - Kiora Pharmaceuticals encourages investors to follow the company on social media and visit its website for relevant updates [4]